Cargando…

The role of chemoprevention by selective cyclooxygenase-2 inhibitors in colorectal cancer patients - a population-based study

BACKGROUND: There are limited population-based studies focusing on the chemopreventive effects of selective cyclooxygenase-2 (COX-2) inhibitors against colorectal cancer. The purpose of this study is to assess the trends and dose–response effects of various medication possession ratios (MPR) of sele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yi-Hsin, Yang, Yea-Huei Kao, Cheng, Ching-Lan, Ho, Pei-Shan, Ko, Ying-Chin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530430/ https://www.ncbi.nlm.nih.gov/pubmed/23217168 http://dx.doi.org/10.1186/1471-2407-12-582

Ejemplares similares

Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors
por: Ganduri, Vinutna, et al.
Publicado: (2022)

Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer
por: Ding, Xian-Zhong, et al.
Publicado: (2003)

Celecoxib: a selective cyclooxygenase-2 inhibitor
por: Gandelman, M
Publicado: (2003)

Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo
por: Li, Wei, et al.
Publicado: (2011)

How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy
por: Tang, Ya-Chu, et al.
Publicado: (2023)

Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
por: Park, Won, et al.
Publicado: (2008)

Chemopreventive Effect of N‐(2‐Cyclohexyloxy‐4‐nitrophenyl)methane Sulfonamide (NS‐398), a Selective Cyclooxygenase‐2 Inhibitor, in Rat Colon Carcinogenesis Induced by Azoxymethane
por: Yoshimi, Naoki, et al.
Publicado: (1999)

Cyclooxygenase-1-selective inhibitor SC-560
por: Long, Sihui, et al.
Publicado: (2009)

The Role of Cyclooxygenase-2 in Colorectal Cancer
por: Sheng, Juan, et al.
Publicado: (2020)

Comparative Effectiveness of Bevacizumab versus Cetuximab in Metastatic Colorectal Cancer Patients without Primary Tumor Resection
por: Su, Yi-Chia, et al.
Publicado: (2022)

Apoptosis Induced by NS‐398, a Selective Cyclooxygenase‐2 Inhibitor, in Human Colorectal Cancer Cell Lines
por: Kara, Akira, et al.
Publicado: (1997)

Renal Effects of Prostaglandins and Cyclooxygenase-2 Inhibitors
por: Kim, Gheun-Ho
Publicado: (2008)

Reducing Medication Errors by Adopting Automatic Dispensing Cabinets in Critical Care Units
por: Tu, Hui-Ning, et al.
Publicado: (2023)

Chemoprevention of Colorectal Cancer by Dietary Compounds
por: Costea, Teodora, et al.
Publicado: (2018)

Chemoprevention by Nimesulide, a Selective Cyclooxygenase‐2 Inhibitor, of 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP)‐induced Mammary Gland Carcinogenesis in Rats
por: Nakatsugi, Seiichi, et al.
Publicado: (2000)

Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects
por: Yang, Ling, et al.
Publicado: (2022)

Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?
por: Manzano, A., et al.
Publicado: (2012)

Cannabinoid system and cyclooxygenases inhibitors
por: Păunescu, H, et al.
Publicado: (2011)

Effects of selective cyclooxygenase‐2 inhibitor robenacoxib on primary cells derived from feline injection‐site sarcoma
por: Lu, Chen‐Hui, et al.
Publicado: (2023)

Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma
por: Seliger, Corinna, et al.
Publicado: (2016)

Differential effects of selective and non-selective cyclooxygenase inhibitors on fecal microbiota in adult horses
por: Whitfield-Cargile, Canaan M., et al.
Publicado: (2018)

Using spatial analysis to demonstrate the heterogeneity of the cardiovascular drug-prescribing pattern in Taiwan
por: Cheng, Ching-Lan, et al.
Publicado: (2011)

Cyclooxygenase 2 expression in pterygium
por: Chiang, Chun-Chi, et al.
Publicado: (2007)

Chemoprevention of colorectal cancer in general population and high-risk population: a systematic review and network meta-analysis
por: Ma, Ye, et al.
Publicado: (2023)

Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population
por: Chapelle, Nicolas, et al.
Publicado: (2020)

Colorectal Cancer Chemoprevention by Mesalazine and Its Derivatives
por: Stolfi, Carmine, et al.
Publicado: (2012)

Chemoprevention of colorectal cancer: Past, present, and future
por: Umezawa, Shotaro, et al.
Publicado: (2019)

Colorectal cancer chemoprevention: is aspirin still in the game?
por: Grancher, Adrien, et al.
Publicado: (2022)

The Cancer Chemopreventive and Therapeutic Potential of Tetrahydrocurcumin
por: Lai, Ching-Shu, et al.
Publicado: (2020)

The effect of cyclooxygenase-2 selective inhibitors on the proliferation and apoptosis of human articular chondrocytes
por: Song, YW, et al.
Publicado: (2003)

Roles of Opioid Receptor Subtype in the Spinal Antinociception of Selective Cyclooxygenase 2 Inhibitor
por: Choi, Cheol Hun, et al.
Publicado: (2010)

Effects of a selective cyclooxygenase-2 inhibitor (celecoxib) on fracture healing in rats
por: Li, Kang-Hua, et al.
Publicado: (2013)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2012)

A Case of Acute Myocardial Infarction Induced by Selective Cyclooxygenase-2 Inhibitor
por: Seo, Kyoung-Woo, et al.
Publicado: (2017)

Effects of Aspirin or Clopidogrel on Colorectal Cancer Chemoprevention in Patients with Type 2 Diabetes Mellitus
por: Kuan, Yi-Chun, et al.
Publicado: (2019)

Cyclooxygenase-2 inhibitors: promise or peril?
por: Mengle-Gaw, Laurel J, et al.
Publicado: (2002)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
por: Smith, Francine G., et al.
Publicado: (2012)

Real‐world evidence of population differences in allopurinol‐related severe cutaneous adverse reactions in East Asians: A population‐based cohort study
por: Sato, Tsugumichi, et al.
Publicado: (2021)

Detecting Potential Adverse Drug Reactions Using a Deep Neural Network Model
por: Wang, Chi-Shiang, et al.
Publicado: (2019)

Selective cyclooxygenase inhibitors increase paclitaxel sensitivity in taxane-resistant ovarian cancer by suppressing P-glycoprotein expression
por: Lee, Jung-Pil, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_74r5r0v9cr1ou1o9hut7op7oka